{"id":48040,"date":"2022-09-07T08:01:41","date_gmt":"2022-09-07T06:01:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/"},"modified":"2022-09-07T08:01:41","modified_gmt":"2022-09-07T06:01:41","slug":"onward-announces-participation-at-upcoming-investor-events-in-september","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/","title":{"rendered":"ONWARD Announces Participation at Upcoming Investor Events in September"},"content":{"rendered":"<div>\n<p>EINDHOVEN, Netherlands &amp; LAUSANNE, Switzerland&#8211;(BUSINESS WIRE)&#8211;ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that management will participate in the following upcoming investor events in September:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220906005921\/en\/1562484\/5\/Logo_Onward.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220906005921\/en\/1562484\/21\/Logo_Onward.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>KBC Securities Virtual Life Sciences Conference<br \/>\n<br \/><\/b>September 16, 2022<br \/>\n<br \/>Dave Marver, CEO, and Lara Smith Weber, CFO, will participate in the conference and give a company presentation.\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fbtov.vc%2Fbtov-investors-talks-and-portfolio-day-2022%2F&amp;esheet=52859441&amp;newsitemid=20220906005921&amp;lan=en-US&amp;anchor=btov+Portfolio+Day&amp;index=1&amp;md5=24d2b9a70e2803ea7225e08de1a1a07b\" rel=\"nofollow noopener\" shape=\"rect\"><b>btov Portfolio Day<\/b><\/a><b><br \/><\/b>September 21, 2022<br \/>\n<br \/>Berlin, Germany<br \/>\n<br \/>Lara Smith Weber, CFO, will give a company presentation.\n<\/li>\n<\/ul>\n<p>\nInformation on upcoming conferences is available in the investor section of the ONWARD website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.onwd.com%2Fnews-events&amp;esheet=52859441&amp;newsitemid=20220906005921&amp;lan=en-US&amp;anchor=https%3A%2F%2Fir.onwd.com%2Fnews-events&amp;index=2&amp;md5=b7b4decd4a8117def3b9b5cc581fa2da\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/ir.onwd.com\/news-events<\/a>.\n<\/p>\n<p>\n<b>About ONWARD Medical<\/b>\n<\/p>\n<p>\nONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries. ONWARD\u2019s work builds on more than a decade of basic science and preclinical research conducted at the world\u2019s leading neuroscience laboratories. ONWARD\u2019s ARC Therapy, which can be delivered by implantable (ARC<sup>IM<\/sup>) or external (ARC<sup>EX<\/sup>) systems, is designed to deliver targeted, programmed spinal cord stimulation to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life. ONWARD has received three Breakthrough Device Designations from the U.S. FDA, encompassing both ARC<sup>IM <\/sup>and ARC<sup>EX<\/sup>. ARC<sup>EX<\/sup> is an external, non-invasive platform consisting of a wearable stimulator and wireless programmer. The company\u2019s first pivotal trial, called Up-LIFT, evaluating the ability of ARC<sup>EX<\/sup> Therapy to improve upper extremity strength and function, completed enrollment in December 2021 with 65 subjects worldwide. Topline results are expected in September 2022. ARC<sup>IM<\/sup> consists of an implantable pulse generator and lead placed near the spinal cord. The company completed its first-in-human use of the ARC<sup>IM<\/sup> neurostimulator in May 2022.\n<\/p>\n<p>\nONWARD is headquartered at the High Tech Campus in Eindhoven, the Netherlands. It maintains a significant team in Lausanne, Switzerland, and has a growing U.S. presence in Boston, Massachusetts, USA. For additional information about the company, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.onwd.com%2F&amp;esheet=52859441&amp;newsitemid=20220906005921&amp;lan=en-US&amp;anchor=ONWD.com&amp;index=3&amp;md5=bde4a4c738a89ecbe438b3932cc4c6c3\" rel=\"nofollow noopener\" shape=\"rect\">ONWD.com<\/a>. To access our 2022 Financial Calendar, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.onwd.com%2F&amp;esheet=52859441&amp;newsitemid=20220906005921&amp;lan=en-US&amp;anchor=IR.ONWD.com&amp;index=4&amp;md5=0bfe43166fcf3dfaf7bfa6bad7fa440a\" rel=\"nofollow noopener\" shape=\"rect\">IR.ONWD.com<\/a>.\n<\/p>\n<p>\n<b>Disclaimer<\/b>\n<\/p>\n<p>\nCertain statements, beliefs, and opinions in this press release are forward-looking, which reflect the Company or, as appropriate, the Company directors\u2019 current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person\u2019s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nFor Company Enquiries:<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#105;&#x6e;&#102;&#x6f;&#64;&#x6f;n&#x77;d&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#110;f&#x6f;&#64;o&#x6e;&#119;d&#x2e;&#99;o&#x6d;<\/a>\n<\/p>\n<p>\nFor Media Enquiries:<br \/>\n<br \/>MC Services AG<br \/>\n<br \/>US: Laurie Doyle, P: +1 339 832 0752<br \/>\n<br \/>Europe: Dr. Claudia Riedl, Kaja Skorka, P: +49 89 210 228 0<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;t&#111;&#x3a;&#109;&#x65;d&#105;&#x61;&#64;&#x6f;n&#x77;&#x64;&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#109;&#101;&#x64;i&#97;&#x40;&#x6f;n&#119;&#x64;&#x2e;c&#111;&#x6d;<\/a>\n<\/p>\n<p>\nFor Investor Enquiries:<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#105;&#x6e;&#118;&#x65;&#115;&#x74;o&#x72;s&#64;&#x6f;&#110;&#x77;d&#x2e;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#110;&#x76;&#x65;s&#x74;&#111;r&#x73;&#64;o&#x6e;&#119;&#x64;&#x2e;c&#x6f;&#109;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>EINDHOVEN, Netherlands &amp; LAUSANNE, Switzerland&#8211;(BUSINESS WIRE)&#8211;ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that management will participate in the following upcoming investor events in September: KBC Securities Virtual Life Sciences Conference September 16, 2022 Dave Marver, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48040","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ONWARD Announces Participation at Upcoming Investor Events in September - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONWARD Announces Participation at Upcoming Investor Events in September - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"EINDHOVEN, Netherlands &amp; LAUSANNE, Switzerland&#8211;(BUSINESS WIRE)&#8211;ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that management will participate in the following upcoming investor events in September: KBC Securities Virtual Life Sciences Conference September 16, 2022 Dave Marver, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-07T06:01:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220906005921\/en\/1562484\/21\/Logo_Onward.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ONWARD Announces Participation at Upcoming Investor Events in September\",\"datePublished\":\"2022-09-07T06:01:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/\"},\"wordCount\":650,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005921\\\/en\\\/1562484\\\/21\\\/Logo_Onward.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/\",\"name\":\"ONWARD Announces Participation at Upcoming Investor Events in September - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005921\\\/en\\\/1562484\\\/21\\\/Logo_Onward.jpg\",\"datePublished\":\"2022-09-07T06:01:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005921\\\/en\\\/1562484\\\/21\\\/Logo_Onward.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220906005921\\\/en\\\/1562484\\\/21\\\/Logo_Onward.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-participation-at-upcoming-investor-events-in-september\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONWARD Announces Participation at Upcoming Investor Events in September\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ONWARD Announces Participation at Upcoming Investor Events in September - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/","og_locale":"en_US","og_type":"article","og_title":"ONWARD Announces Participation at Upcoming Investor Events in September - Pharma Trend","og_description":"EINDHOVEN, Netherlands &amp; LAUSANNE, Switzerland&#8211;(BUSINESS WIRE)&#8211;ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury (SCI), today announced that management will participate in the following upcoming investor events in September: KBC Securities Virtual Life Sciences Conference September 16, 2022 Dave Marver, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-07T06:01:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220906005921\/en\/1562484\/21\/Logo_Onward.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ONWARD Announces Participation at Upcoming Investor Events in September","datePublished":"2022-09-07T06:01:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/"},"wordCount":650,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220906005921\/en\/1562484\/21\/Logo_Onward.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/","url":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/","name":"ONWARD Announces Participation at Upcoming Investor Events in September - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220906005921\/en\/1562484\/21\/Logo_Onward.jpg","datePublished":"2022-09-07T06:01:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220906005921\/en\/1562484\/21\/Logo_Onward.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220906005921\/en\/1562484\/21\/Logo_Onward.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/onward-announces-participation-at-upcoming-investor-events-in-september\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ONWARD Announces Participation at Upcoming Investor Events in September"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48040","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48040"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48040\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48040"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48040"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48040"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}